Literature DB >> 25524906

A London experience 1995-2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease.

P M Ferraro1, W G Robertson2, N Johri3, A Nair3, G Gambaro3, L Shavit2, S H Moochhala3, R J Unwin3.   

Abstract

BACKGROUND: Kidney stone disease has an estimated prevalence of around 10%. Genetic as well as environmental factors are thought to play an important role in the pathogenesis of renal stones. AIM: The aim of our study was to analyse and report the main characteristics of patients with kidney stones attending a large UK metabolic stone clinic in London between 1995 and 2012.
DESIGN: A cross-sectional study.
METHODS: Analysis of data from stone formers attending the University College and Royal Free Hospitals' metabolic stone clinic from 1995 to 2012. Demographic, clinical, dietary and biochemical characteristics have been summarized and analysed for men and women separately; trends over time have also been analysed.
RESULTS: Of the 2861 patients included in the analysis, 2016 (70%) were men with an average age of 47 years (range 18-87 years) and median duration of disease of 6 years (range 0-60 years). The prevalence of low urine volume, hypercalciuria, hyperoxaluria, hyperuricosuria and hypocitraturia was 5.6%, 38%, 7.9%, 18% and 23%, respectively. The prevalence of several risk factors for stones increased over time. The majority of stones were mixed, with around 90% composed of calcium salts in varying proportion.
CONCLUSION: Our findings in a large cohort of patients attending a London-based stone clinic over the past 20 years show differences in distributions of risk factors for stones for men and women, as well as metabolic profiles and stone composition. The impact of most risk factors for stones appeared to change over time.
© The Author 2014. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25524906     DOI: 10.1093/qjmed/hcu251

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  5 in total

1.  Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan.

Authors:  Matteo Bargagli; Nasser A Dhayat; Manuel Anderegg; Mariam Semmo; Uyen Huynh-Do; Bruno Vogt; Pietro Manuel Ferraro; Daniel G Fuster
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-11       Impact factor: 8.237

2.  Chlorthalidone vs. potassium citrate in a model of hypercalciuria: differential effects on stone and bone.

Authors:  Gianmarco Lombardi; Pietro Manuel Ferraro; Giovanni Gambaro
Journal:  Ann Transl Med       Date:  2019-09

3.  Impact of potassium citrate on urinary risk profile, glucose and lipid metabolism of kidney stone formers in Switzerland.

Authors:  Anna Wiegand; Gioia Fischer; Harald Seeger; Daniel Fuster; Nasser Dhayat; Olivier Bonny; Thomas Ernandez; Min-Jeong Kim; Carsten A Wagner; Nilufar Mohebbi
Journal:  Clin Kidney J       Date:  2019-08-19

Review 4.  Nephrolithiasis: A Red Flag for Cardiovascular Risk.

Authors:  Alessia Gambaro; Gianmarco Lombardi; Chiara Caletti; Flavio Luciano Ribichini; Pietro Manuel Ferraro; Giovanni Gambaro
Journal:  J Clin Med       Date:  2022-09-20       Impact factor: 4.964

5.  Urinary metabolic profile and stone composition in kidney stone formers with and without heart disease.

Authors:  Matteo Bargagli; Shabbir Moochhala; William G Robertson; Giovanni Gambaro; Gianmarco Lombardi; Robert J Unwin; Pietro Manuel Ferraro
Journal:  J Nephrol       Date:  2021-06-21       Impact factor: 3.902

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.